{"DataElement":{"publicId":"3119721","version":"1","preferredName":"New Neoplasm Event Type","preferredDefinition":"Text term to identify a new tumor event.","longName":"3119702v1.0:3119718v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3119702","version":"1","preferredName":"New Neoplasm Event","preferredDefinition":"New; having no previous example or precedent or parallel._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Event; something that happens at a given place and time.","longName":"3108264v1.0:2419225v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3108264","version":"1","preferredName":"New Neoplasm","preferredDefinition":"New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25586:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8883C12C-4F39-5E58-E040-BB89AD437DB2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2419225","version":"1","preferredName":"Event","preferredDefinition":"Event; something that happens at a given place and time.","longName":"C25499","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Event","conceptCode":"C25499","definition":"Something that happens at a given place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0307659E-F14B-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"PWEST","dateCreated":"2005-10-14","modifiedBy":"ONEDATA","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AE1E2A1-46D9-6C31-E040-BB89AD434C6B","latestVersionIndicator":"Yes","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3119718","version":"1","preferredName":"Neoplasm Event Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Event; something that happens at a given place and time._Type; a subdivision of a particular kind of thing.","longName":"3119718v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Both Locoregional and Distant Metastasis","valueDescription":"Local-Regional And Distant Metastasis","ValueMeaning":{"publicId":"3119719","version":"1","preferredName":"Local-Regional And Distant Metastasis","longName":"3119719","preferredDefinition":"Local-Regional; affecting only a restricted part or area of the body.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local-Regional","conceptCode":"C25388","definition":"Of or belonging to both a local and regional area of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Distant Metastasis","conceptCode":"C18206","definition":"A biological process that involves the transfer and growth of cancer cells from the site of the primary tumor. Relocation of malignant cells during metastasis can be restricted to movement within a specific tissue/organ or may entail migration to a distal locus within the body. This phenotype is a characteristic of all malignant tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AE297D5-1C99-34B4-E040-BB89AD4342A2","latestVersionIndicator":"Yes","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AE297D5-1CB2-34B4-E040-BB89AD4342A2","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"ONEDATA","dateModified":"2010-07-08","deletedIndicator":"No"},{"value":"Distant Metastasis","valueDescription":"Distant Metastasis","ValueMeaning":{"publicId":"2568046","version":"1","preferredName":"Distant Metastasis","longName":"2568046","preferredDefinition":"Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distant Metastasis","conceptCode":"C18206","definition":"A biological process that involves the transfer and growth of cancer cells from the site of the primary tumor. Relocation of malignant cells during metastasis can be restricted to movement within a specific tissue/organ or may entail migration to a distal locus within the body. This phenotype is a characteristic of all malignant tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AE297D5-1CBC-34B4-E040-BB89AD4342A2","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"ONEDATA","dateModified":"2010-07-08","deletedIndicator":"No"},{"value":"Locoregional Disease","valueDescription":"Local-Regional","ValueMeaning":{"publicId":"3113358","version":"1","preferredName":"Local-Regional","longName":"3113358","preferredDefinition":"Local-Regional; affecting only a restricted part or area of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local-Regional","conceptCode":"C25388","definition":"Of or belonging to both a local and regional area of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899DCB78-FC24-1174-E040-BB89AD430323","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AE297D5-1CD0-34B4-E040-BB89AD4342A2","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"ONEDATA","dateModified":"2010-07-08","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"928272C8-6765-BAA6-E040-BB89AD430F0C","beginDate":"2010-10-13","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-13","modifiedBy":"ONEDATA","dateModified":"2010-10-13","deletedIndicator":"No"},{"value":"New Primary Tumor","valueDescription":"New Primary Neoplasm","ValueMeaning":{"publicId":"3151121","version":"1","preferredName":"New Primary Neoplasm","longName":"3151121","preferredDefinition":"New; having no previous example or precedent or parallel.: The original tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"928272C8-6772-BAA6-E040-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2010-10-13","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"928272C8-678B-BAA6-E040-BB89AD430F0C","beginDate":"2010-10-13","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-13","modifiedBy":"ONEDATA","dateModified":"2010-10-13","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":"Metastatic Neoplasm","ValueMeaning":{"publicId":"2718408","version":"1","preferredName":"Metastatic Neoplasm","longName":"2718408","preferredDefinition":"A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Neoplasm","conceptCode":"C3261","definition":"A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D6C657-84A8-3BA0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"928272C8-679F-BAA6-E040-BB89AD430F0C","beginDate":"2010-10-13","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-13","modifiedBy":"ONEDATA","dateModified":"2010-10-13","deletedIndicator":"No"},{"value":"Locoregional (Urothelial tumor event)","valueDescription":"Urothelial Carcinoma","ValueMeaning":{"publicId":"3155848","version":"1","preferredName":"Urothelial Carcinoma","longName":"3155848","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-84AC-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9943CCF6-FFAA-5BDE-E040-BB89AD431006","beginDate":"2011-01-07","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-07","modifiedBy":"ONEDATA","dateModified":"2011-01-07","deletedIndicator":"No"},{"value":"No New Tumor Event","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9943CCF6-FFBE-5BDE-E040-BB89AD431006","beginDate":"2011-01-07","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-07","modifiedBy":"ONEDATA","dateModified":"2011-01-07","deletedIndicator":"No"},{"value":"Biochemical evidence of disease","valueDescription":"Biochemical Evidence of Disease","ValueMeaning":{"publicId":"3166454","version":"1","preferredName":"Biochemical Evidence of Disease","longName":"3166454","preferredDefinition":"Of or relating to biochemistry; involving chemical processes in living organisms.: Knowledge on which to base belief.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biochemical","conceptCode":"C25434","definition":"Of or relating to biochemistry; involving chemical processes in living organisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9766E8FC-EFBE-9808-E040-BB89AD434090","latestVersionIndicator":"Yes","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9766E8FC-EFD7-9808-E040-BB89AD434090","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"ONEDATA","dateModified":"2010-12-14","deletedIndicator":"No"},{"value":"Extrahepatic Recurrence","valueDescription":"Extrahepatic","ValueMeaning":{"publicId":"3177657","version":"1","preferredName":"Extrahepatic","longName":"3177657","preferredDefinition":"(extra-heh-PAT-ik) Located or occurring outside the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrahepatic","conceptCode":"C28358","definition":"Located or occurring outside the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9803D2A5-1D58-92F4-E040-BB89AD436197","latestVersionIndicator":"Yes","beginDate":"2010-12-22","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9803D2A5-1D71-92F4-E040-BB89AD436197","beginDate":"2010-12-22","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-22","modifiedBy":"ONEDATA","dateModified":"2010-12-22","deletedIndicator":"No"},{"value":"Intrahepatic Recurrence","valueDescription":"Intrahepatic","ValueMeaning":{"publicId":"3177658","version":"1","preferredName":"Intrahepatic","longName":"3177658","preferredDefinition":"(in-tra-hep-AT-ik) Within the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic","conceptCode":"C13808","definition":"Within the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9803D2A5-1D7B-92F4-E040-BB89AD436197","latestVersionIndicator":"Yes","beginDate":"2010-12-22","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9803D2A5-1D96-92F4-E040-BB89AD436197","beginDate":"2010-12-22","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-22","modifiedBy":"ONEDATA","dateModified":"2010-12-22","deletedIndicator":"No"},{"value":"Locoregional Recurrence","valueDescription":"Recurrence Local-Regional","ValueMeaning":{"publicId":"3203348","version":"1","preferredName":"Recurrence Local-Regional","longName":"3203348","preferredDefinition":"To occur again.: Local-Regional; affecting only a restricted part or area of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Local-Regional","conceptCode":"C25388","definition":"Of or belonging to both a local and regional area of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8852A4-6378-4FEA-E040-BB89AD4347E1","latestVersionIndicator":"Yes","beginDate":"2011-03-15","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E8852A4-6391-4FEA-E040-BB89AD4347E1","beginDate":"2011-03-15","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-15","modifiedBy":"ONEDATA","dateModified":"2011-03-15","deletedIndicator":"No"},{"value":"New primary melanoma","valueDescription":"New Primary Melanoma","ValueMeaning":{"publicId":"3422996","version":"1","preferredName":"New Primary Melanoma","longName":"3422996","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: Occurring first in time or sequence; original; of greatest rank or importance or value.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC404DE9-F15D-F68A-E040-BB89AD43771E","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC404DE9-F176-F68A-E040-BB89AD43771E","beginDate":"2012-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-27","modifiedBy":"ONEDATA","dateModified":"2012-03-27","deletedIndicator":"No"},{"value":"Regional lymph node","valueDescription":"Regional Lymph Node","ValueMeaning":{"publicId":"3422988","version":"1","preferredName":"Regional Lymph Node","longName":"3422988","preferredDefinition":"A lymph node that drains lymph from a region of interest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Regional Lymph Node","conceptCode":"C49018","definition":"A lymph node that drains lymph from a region of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC3FA497-ED88-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC3FA497-EDA1-F133-E040-BB89AD435473","beginDate":"2012-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-27","modifiedBy":"ONEDATA","dateModified":"2012-03-27","deletedIndicator":"No"},{"value":"Intrapleural Progression","valueDescription":"Intrapleural Cancer Progression","ValueMeaning":{"publicId":"3630778","version":"1","preferredName":"Intrapleural Cancer Progression","longName":"3630778","preferredDefinition":"Within the pleural cavity.: A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrapleural","conceptCode":"C96907","definition":"Within the pleural cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cancer Progression","conceptCode":"C19987","definition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF81A173-0BEF-62F5-E040-BB89AD4336D3","latestVersionIndicator":"Yes","beginDate":"2012-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF81A173-0C08-62F5-E040-BB89AD4336D3","beginDate":"2012-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-27","modifiedBy":"ONEDATA","dateModified":"2012-11-27","deletedIndicator":"No"},{"value":"Recurrence","valueDescription":"Recurrent Neoplasm","ValueMeaning":{"publicId":"3027772","version":"1","preferredName":"Recurrent Neoplasm","longName":"3027772","preferredDefinition":"The reemergence of neoplasm after a period of remission","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Neoplasm","conceptCode":"C4798","definition":"The reemergence of a neoplasm after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81FEA524-6285-3572-E040-BB89AD431BC6","latestVersionIndicator":"Yes","beginDate":"2010-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF720E1D-19CA-9B86-E040-BB89AD437478","beginDate":"2010-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Progression of Disease","valueDescription":"Cancer Progression","ValueMeaning":{"publicId":"3774160","version":"1","preferredName":"Cancer Progression","longName":"3774160","preferredDefinition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Progression","conceptCode":"C19987","definition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE418214-6016-966D-E040-BB89AD43052E","latestVersionIndicator":"Yes","beginDate":"2013-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE418214-602F-966D-E040-BB89AD43052E","beginDate":"2013-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-03","modifiedBy":"ONEDATA","dateModified":"2013-06-03","deletedIndicator":"No"},{"value":"Metachronous Testicular Tumor","valueDescription":"Metachronous Testicular Tumor","ValueMeaning":{"publicId":"4575918","version":"1","preferredName":"Metachronous Testicular Tumor","longName":"4575918","preferredDefinition":"A malignant tumor that arises at a site separate from another, primary malignant tumor in the same anatomic system.  It is not clear if metachronous malignant neoplasms represent new primary tumors or metastatic disease.  Examples include metachronous osteosarcoma of the bones that develops in patients with known primary bone osteosarcoma, and metachronous Wilms' tumor that affects the opposite kidney in patients with a history of Wilms' tumor.: A benign or malignant neoplasm that affects the testis.  Representative examples include fibroma, thecoma, benign Sertoli cell tumor, seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metachronous Malignant Neoplasm","conceptCode":"C38156","definition":"A malignant tumor that arises at a site separate from another, primary malignant tumor in the same anatomic system.  It is not clear if metachronous malignant neoplasms represent new primary tumors or metastatic disease.  Examples include metachronous osteosarcoma of the bones that develops in patients with known primary bone osteosarcoma, and metachronous Wilms' tumor that affects the opposite kidney in patients with a history of Wilms' tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Testicular Neoplasm","conceptCode":"C3404","definition":"A benign or malignant neoplasm that affects the testis.  Representative examples include fibroma, thecoma, benign Sertoli cell tumor, seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07478C2A-AE24-F9B1-E050-BB89AD4353CF","latestVersionIndicator":"Yes","beginDate":"2014-11-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07478C2A-AE3D-F9B1-E050-BB89AD4353CF","beginDate":"2014-11-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-11-07","modifiedBy":"ONEDATA","dateModified":"2014-11-07","deletedIndicator":"No"},{"value":"New primary diagnosis","valueDescription":"New primary diagnosis","ValueMeaning":{"publicId":"2576515","version":"1","preferredName":"New primary diagnosis","longName":"2576515","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: Occurring first in time or sequence; original; of greatest rank or importance or value.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F7F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"COOPERM","dateModified":"2017-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BDF06A8-26D3-63D6-E053-F662850A0FB0","beginDate":"2017-03-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-29","modifiedBy":"ONEDATA","dateModified":"2017-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3119717","version":"1","preferredName":"Neoplasm Event Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Event; something that happens at a given place and time.:Type; a subdivision of a particular kind of thing.","longName":"C3262:C25499:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Event","conceptCode":"C25499","definition":"Something that happens at a given place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AE297D5-1C6F-34B4-E040-BB89AD4342A2","latestVersionIndicator":"Yes","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"ONEDATA","dateModified":"2010-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AE297D5-1C80-34B4-E040-BB89AD4342A2","latestVersionIndicator":"Yes","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"COOPERM","dateModified":"2017-03-29","changeDescription":"Added one PV for TCGA by request of T. Lichtenberg (JP) 12/7/2010 Added one PV for TCGA by request of T. Lichtenberg mc 12/14/10 Added two PVs for TCGA by request of T. Lichtenberg mc 12/22/10  Added two PVs for TCGA by request of T. Lichtenberg sw 1/7/11 Added one PV for TCGA by request of S. Ratliff (JP) 3/2011. Added one PV per request by T.Lichtenberg mc 6/3/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[{"name":"new_neoplasm_event_type","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Type of New Tumor Event","type":"Preferred Question Text","description":"Type of New Tumor Event","url":null,"context":"NCIP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"New Event Type","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AE297D5-1CFD-34B4-E040-BB89AD4342A2","latestVersionIndicator":"Yes","beginDate":"2010-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-08","modifiedBy":"TSESU","dateModified":"2018-07-10","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 7/2010; Added alt text for CTSP task, ylu 3/27/17.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}